Press Releases
Press Releases
Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application, for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol®...
Press Releases
PharMerica Comments on FTC Decision to Block Omnicare’s Hostile Tender Offer
PharMerica Corporation , a national provider of institutional pharmacy and hospital pharmacy management services, today commented on the decision by the Federal Trade Commission to sue to block Omnicare’s unsolicited offer to acquire PharMerica. ...
Press Releases
Spectrum Pharmaceuticals Strengthens Commercial Operations
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the promotions of Rick Gonzalez to Senior Vice President, Commercial; Andrew W. Amstrup...
Press Releases
Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLC
Greenleaf Health LLC today announced that Michael Chappell, former Acting Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (“FDA”), has joined the firm as Senior Advisor. Greenleaf Health is a full service...
Press Releases
Rhenovia Pharma opens first US office
Rhenovia Pharma SAS, a biotechnology company specializing in biosimulation applied to the discovery of new medications to treat brain diseases such as Alzheimer’s, today announces its first international subsidiary, Rhenovia Inc, incorporated in Delaware. Rhenovia’s new...
Press Releases
NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product
NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced the termination of certain license agreements with Talon Therapeutics, Inc. and Par Pharmaceutical Companies, Inc., relating to the development and commercialization...
Press Releases
Polyplus-transfection launches the next generation PEI transfection reagent for bioproduction
Polyplus-transfection SA, specializing in the development of innovative solutions for transfection, today announces the launch of PEIpro, the next generation linear PEI (polyethylenimine) transfection reagent for large scale production of proteins, antibodies and viral vectors. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read